Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Rizos

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Pigment Cell & Melanoma Research|April 22, 2022
Protein-based classification of melanoma differentiation subtypesSu Yin Lim, Bernadette Pedersen, Helen Rizos
Biomolecules|October 20, 2020
Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and ProgressionZizhen Ming, Su Yin Lim, Helen Rizos
Cell Cycle (Georgetown, Tex.)|February 11, 2005
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosisStuart Gallagher, Richard F Kefford, Helen Rizos
Cell Cycle (Georgetown, Tex.)|May 7, 2005
p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partnersHelen Rizos, Sarah Woodruff, Richard F Kefford
Oncolytic Virotherapy|August 12, 2016
Oncolytic virotherapy using herpes simplex virus: how far have we come?Nicolas As Sokolowski, Helen Rizos, Russell J Diefenbach
Cancer Cell|December 15, 2020
Dosing of BRAK and MEK Inhibitors in Melanoma: No Point in Taking a BreakJenny H Lee, Matteo S Carlino, Helen Rizos
Melanoma Management|September 14, 2020
Methylated circulating tumor DNA as a biomarker in cutaneous melanomaRussell J Diefenbach, Jenny H Lee, Helen Rizos
Oncoscience|January 17, 2015
Resistance to c-Kit inhibitors in melanoma: insights for future therapiesMatteo S Carlino, Jason R Todd, Helen Rizos
Cancer|May 26, 2017
Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanomaSu Yin Lim, Alexander M Menzies, Helen Rizos
The International Journal of Biochemistry & Cell Biology|April 8, 2006
The ARF tumour suppressorStuart J Gallagher, Richard F Kefford, Helen Rizos
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Pigment Cell & Melanoma Research|April 22, 2022
Protein-based classification of melanoma differentiation subtypesSu Yin Lim, Bernadette Pedersen, Helen Rizos
Biomolecules|October 20, 2020
Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and ProgressionZizhen Ming, Su Yin Lim, Helen Rizos
Cell Cycle (Georgetown, Tex.)|February 11, 2005
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosisStuart Gallagher, Richard F Kefford, Helen Rizos
Cell Cycle (Georgetown, Tex.)|May 7, 2005
p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partnersHelen Rizos, Sarah Woodruff, Richard F Kefford
Oncolytic Virotherapy|August 12, 2016
Oncolytic virotherapy using herpes simplex virus: how far have we come?Nicolas As Sokolowski, Helen Rizos, Russell J Diefenbach
Cancer Cell|December 15, 2020
Dosing of BRAK and MEK Inhibitors in Melanoma: No Point in Taking a BreakJenny H Lee, Matteo S Carlino, Helen Rizos
Melanoma Management|September 14, 2020
Methylated circulating tumor DNA as a biomarker in cutaneous melanomaRussell J Diefenbach, Jenny H Lee, Helen Rizos
Oncoscience|January 17, 2015
Resistance to c-Kit inhibitors in melanoma: insights for future therapiesMatteo S Carlino, Jason R Todd, Helen Rizos
Cancer|May 26, 2017
Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanomaSu Yin Lim, Alexander M Menzies, Helen Rizos
The International Journal of Biochemistry & Cell Biology|April 8, 2006
The ARF tumour suppressorStuart J Gallagher, Richard F Kefford, Helen Rizos
Pageof 14